Target intelligence / Profile preview

Signal transducer and activator of transcription protein family member (STAT (for family); specific members are STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B, STAT6)

Target
STAT (for family); specific members are STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B, STAT6
Molecular classification
Transcription factor, DNA-binding protein
01

Overview

STAT proteins are a family of latent cytoplasmic transcription factors that, upon activation by cytokine or growth factor signaling, are phosphorylated, dimerize, and translocate to the nucleus where they regulate gene expression. They are essential for processes such as immune cell development, proliferation, and the response to inflammation. Dysregulation of STAT signaling, especially STAT3 and STAT5, is implicated in various cancers, chronic inflammation, and immune system disorders. For structured data purposes, it is recommended to specify the exact STAT protein (e.g., "Signal transducer and activator of transcription 3" for STAT3 or "Signal transducer and activator of transcription 5A" for STAT5A), as each family member can have distinct biological roles and therapeutic relevance.

Other names
STATStat familySignal Transducer and Activator of Transcription
02

Mechanism of action

Inhibition of dimerization or tetramerization of STAT proteins Inhibition of tyrosine phosphorylation to prevent activation Blockade of DNA binding to target genes Inhibition of upstream activators, such as JAK kinases

03

Biological functions

Signal transductionImmune responseCell proliferationCell differentiationApoptosis (cell death)HematopoiesisInflammation
04

Disease associations

CancerInflammationImmune-related diseases (including autoimmune disorders and immunodeficiency)InfectionDevelopmental disorders
05

Safety considerations

Potential immunosuppression due to broad role in immune regulationOff-target effects leading to hematological toxicityRisk of impaired hematopoiesis and normal cellular function when broadly inhibiting STAT activity
06

Interacting drugs

Several experimental inhibitors targeting STAT3 and STAT5 (no widely approved small-molecule direct STAT inhibitors as of 2024)

1 more in the full profile.

07

Biomarkers

Elevated STAT3 or STAT5 activity/phosphorylation may serve as biomarkers for disease prognosis and therapy selection in cancer and immune disorders

Beyond the preview

Go deeper on Signal transducer and activator of transcription protein family member (STAT (for family); specific members are STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B, STAT6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signal transducer and activator of transcription protein family member (STAT (for family); specific members are STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B, STAT6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call